Resultados de procura - Se‐Hoon Lee

Limitar resultados
  1. 1
    Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics

    Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics por Seo‐Yeon Park, Hei Sung Kim, Se‐Hoon Lee, Sungjoo Kim

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Clinicopathologic characteristics of <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> alterations in 6,595 lung cancers

    Clinicopathologic characteristics of <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> alterations in 6,595 lung cancers por Boram Lee, Taebum Lee, Se‐Hoon Lee, Yoon‐La Choi, Joungho Han

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Characterization and Analysis of the Skin Microbiota in Rosacea: Impact of Systemic Antibiotics

    Characterization and Analysis of the Skin Microbiota in Rosacea: Impact of Systemic Antibiotics por Yu Ri Woo, Se‐Hoon Lee, Sang Hyun Cho, Jeong Deuk Lee, Hei Sung Kim

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute

    Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute por Younak Choi, Bhumsuk Keam, Tae Min Kim, Se‐Hoon Lee, Dong‐Wan Kim, Dae Seog Heo

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib por Youjin Kim, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer

    Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer por Song Ee Park, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Analysis of the BRAFV600E Mutation in Central Nervous System Tumors

    Analysis of the BRAFV600E Mutation in Central Nervous System Tumors por Jae Kyung Myung, Hwa Jin Cho, Chul‐Kee Park, Seung-Ki Kim, Se‐Hoon Lee, Sung‐Hye Park

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Molecular Changes Associated with Acquired Resistance to Crizotinib in <i>ROS1</i>-Rearranged Non–Small Cell Lung Cancer

    Molecular Changes Associated with Acquired Resistance to Crizotinib in <i>ROS1</i>-Rearranged Non–Small Cell Lung Cancer por Ahnah Song, Tae Min Kim, Dong‐Wan Kim, Soyeon Kim, Bhumsuk Keam, Se‐Hoon Lee, Dae Seog Heo

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer

    Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer por Eunyoung Lee, Bhumsuk Keam, Dong‐Wan Kim, Tae Min Kim, Se‐Hoon Lee, Doo Hyun Chung, Dae Seog Heo

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis

    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis por Seonggyu Byeon, Jun Soo Ham, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma por Hana Kim, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Keunchil Park, Yong Chan Ahn, Dongryul Oh, Myung‐Ju Ahn

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor

    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor por Sehhoon Park, Seunggyun Ha, Se‐Hoon Lee, Jin Chul Paeng, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence por Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Thyroid Cancer

    Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Thyroid Cancer por Youngkyung Jeon, Sehhoon Park, Se‐Hoon Lee, Tae Hyuk Kim, Sun Wook Kim, Myung‐Ju Ahn, Hyun Ae Jung, Jae Hoon Chung

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Aggressiveness of Cancer-Care near the End-of-Life in Korea

    Aggressiveness of Cancer-Care near the End-of-Life in Korea por Bhumsuk Keam, Djin‐Ye Oh, Se‐Hoon Lee, Dong‐Wook Kim, Mee‐Ran Kim, S. Im, Tae‐Yop Kim, Yung‐Jue Bang, D. S. Heo

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

    Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer por Bo Mi Ku, Yeon Hee Bae, Kyoung Young Lee, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC

    DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC por Sehhoon Park, Hayoon Lee, Boram Lee, Se‐Hoon Lee, Jong‐Mu Sun, Woong‐Yang Park, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer

    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer por Ji Eun Shin, Hyun Ae Jung, Sehhoon Park, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Byoung Yong Shim

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer

    Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer por Soyeon Kim, Tae Min Kim, Dong Wan Kim, Heounjeong Go, Bhumsuk Keam, Se‐Hoon Lee, Ja-Lok Ku, Doo Hyun Chung, Dae Seog Heo

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm

    Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm por Heounjeong Go, Dong‐Wan Kim, Donghyun Kim, Bhumsuk Keam, Tae Min Kim, Se‐Hoon Lee, Dae Seog Heo, Yung‐Jue Bang, Doo Hyun Chung

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: